NYSE$SCL
Stepan Company · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
Stepan's Q2 2024 earnings were impacted by operational expenses, start-up costs, and a criminal social engineering event, but adjusted EBITDA grew.
Stepan Company's second quarter earnings were negatively impacted by higher operational expenses at the Millsdale site, start-up costs for the Pasadena investment, and a criminal fraud event in Asia. Despite these challenges, the company saw volume growth in several core markets and delivered adjusted EBITDA growth of 4%.
- Net income decreased by 25% compared to the prior year, totaling $9.5 million.
- Pre-tax earnings were negatively impacted by $18.9 million due to issues at the Millsdale site, Pasadena investment costs, and a fraud event in Asia.
- EBITDA increased by 3% year-over-year to $47.9 million, while adjusted EBITDA rose by 4% to $47.7 million.
- Global sales volume increased by 4% year-over-year, with Surfactant and Polymer sales volume up by 5% and 2%, respectively.
Headline financials
Revenue & EPS history
Stepan · Revenue · Quarterly
$556M
Revenue by segment
Stepan · $562M total across 3 segments · Q3 2023
- Surfactants$374M-21.3%66.5%
- Polymers$170M-21.1%30.2%
- Specialty Products$18.8M-36.2%3.3%
Forward guidance
The company expects second half EBITDA to improve versus the prior year based on continued volume growth and a significant reduction in second half operational expenses at the Millsdale site. Free cash flow should continue to improve versus prior year driven by the completion of our Pasadena investment, the growth in market volumes, and our continued focus on cost reduction. We believe we are positioned to deliver full year Adjusted EBITDA growth and positive free cash flow.
Tailwinds
- Continued volume growth expected.
- Significant reduction in second half operational expenses at Millsdale site anticipated.
- Ongoing recovery in Rigid Polyols expected.
- Expected second half recovery of the Agricultural Chemicals business.
- Completion of Pasadena investment will drive improved free cash flow.
Headwinds
- Second quarter expenses significantly impacted earnings.
- Higher operational expenses at Millsdale site.
- Start up costs related to Pasadena investment.
- Criminal social engineering event impacted one of our Asia subsidiaries.
- Near-term expenses related to the Asia fraud event are expected.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2024
-0.5%
Avg return
Earnings day
-1.1%
Avg return
5 days after
-0.7%
Avg return
30 days after
43%
28 / 65 earnings
Positive
+12.4%
Q1 2015
Best reaction
-20.4%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +1.1% | -0.7% | -2.7% | |
| Q4 2025 | -20.4% | -24.3% | -25.2% | |
| Q3 2025 | -0.4% | -4.1% | +2.2% | |
| Q1 2025 | +7.1% | +13.8% | +15.2% | |
| Q4 2024 | +0.1% | -0.0% | -7.3% | |
| Q3 2024 | -0.8% | -0.2% | +5.4% | |
| Q2 2024 | -11.0% | -18.9% | -13.8% | |
| Q1 2024 | -0.6% | +1.4% | +0.2% | |
| Q4 2023 | -2.5% | -2.3% | -3.2% | |
| Q3 2023 | +7.9% | +9.1% | +18.7% | |
| Q2 2023 | -3.8% | -0.6% | -10.1% | |
| Q1 2023 | -10.2% | -7.2% | -5.8% | |
| Q4 2022 | -2.4% | -4.5% | -13.3% | |
| Q3 2022 | -2.9% | -0.3% | +10.5% | |
| Q2 2022 | +8.6% | +5.4% | +2.0% | |
| Q1 2022 | +4.9% | +3.9% | +11.7% | |
| Q4 2021 | -3.5% | -5.6% | -9.7% | |
| Q3 2021 | +2.4% | +1.2% | +1.9% | |
| Q2 2021 | -0.1% | +0.2% | -1.0% | |
| Q1 2021 | -0.7% | -0.8% | +2.1% | |
| Q4 2020 | -2.9% | -2.1% | +4.7% | |
| Q3 2020 | -0.5% | +2.0% | +7.0% | |
| Q2 2020 | +7.5% | +7.6% | +12.8% | |
| Q1 2020 | -1.9% | -0.3% | +4.8% | |
| Q4 2019 | -1.6% | -8.3% | -26.6% | |
| Q3 2019 | +0.1% | +3.6% | +1.4% | |
| Q2 2019 | +3.7% | +3.2% | -2.0% | |
| Q1 2019 | -0.2% | -0.2% | -6.2% | |
| Q4 2018 | +1.5% | +0.9% | -7.7% | |
| Q3 2018 | +3.0% | +1.0% | -2.1% | |
| Q2 2018 | +5.3% | +6.4% | +8.8% | |
| Q1 2018 | -17.2% | -18.5% | -20.0% | |
| Q4 2017 | +5.8% | +10.3% | +11.3% | |
| Q3 2017 | -7.0% | -7.3% | -4.3% | |
| Q2 2017 | -7.2% | -10.2% | -15.9% | |
| Q1 2017 | +9.7% | +4.8% | +7.4% | |
| Q4 2016 | -10.3% | -5.9% | -0.7% | |
| Q3 2016 | +6.6% | +2.9% | +11.9% | |
| Q2 2016 | +4.2% | +2.4% | +11.6% | |
| Q1 2016 | +6.6% | — | — | |
| Q4 2015 | +12.0% | — | — | |
| Q3 2015 | +8.8% | — | — | |
| Q2 2015 | -10.6% | — | — | |
| Q1 2015 | +12.4% | — | — | |
| Q4 2014 | -0.6% | — | — | |
| Q3 2014 | -5.2% | — | — | |
| Q2 2014 | -1.5% | — | — | |
| Q1 2014 | -1.7% | — | — | |
| Q4 2013 | -5.1% | — | — | |
| Q3 2013 | +0.6% | — | — | |
| Q2 2013 | +0.7% | — | — | |
| Q1 2013 | -11.4% | — | — | |
| Q2 2010 | -0.5% | — | — | |
| Q4 2012 | -0.1% | — | — | |
| Q3 2012 | -3.8% | — | — | |
| Q2 2012 | -8.0% | — | — | |
| Q1 2011 | +3.6% | — | — | |
| Q1 2012 | +3.9% | — | — | |
| Q4 2009 | +4.7% | — | — | |
| Q4 2011 | +4.7% | — | — | |
| Q3 2011 | -4.5% | — | — | |
| Q3 2010 | -4.5% | — | — | |
| Q4 2010 | -2.0% | — | — | |
| Q2 2011 | -2.0% | — | — | |
| Q1 2010 | +1.7% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro